BSE filing, NSE: PRITHVISOF. Summary written from the filing by ALFA Finder's alert engine.
Prithvi Exchange (India) Ltd: key numbers
- Share price
- ₹96.80
- Market cap
- ₹79.86 Cr
- Revenue (annual)
- ₹3,731 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 40.1×Sector 19.1×
- Promoter holding
- 72.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prithvi Exchange (India) Ltd
All →Prithvi Exchange (India) Other Announcement
Prithvi Exchange (India) Ltd submitted its quarterly shareholding pattern for the period ending 30-Sep-2026. This is a standard regulatory filing detailing the company's equity structure.
Prithvi Exchange (India) Bags New Order from India Tourism Development Corporation Limited
Prithvi Exchange received a Letter of Acceptance from India Tourism Development Corporation for foreign currency collection services. The contract covers a two-year period.
- From
- India Tourism Development Corporation Limited (ITDC)
- Execution
- 2 years
Prithvi Exchange (India) Product Launch
Prithvi Exchange (India) Limited launched its mobile application for customers and a new 'Partner Hub' portal for its business partners to enhance digital service delivery.
Prithvi Exchange (India) Annual General Meeting
Prithvi Exchange (India) Limited held its 31st AGM on August 27, 2026. Shareholders approved a 5% final dividend and the adoption of audited financial statements.
Prithvi Exchange (India) Investor Presentation: Key Takeaways
Prithvi Exchange reported Q1 FY27 revenue of ₹1,108.2 Cr, up 25.11% YoY, despite a 37.5% decline in PAT to ₹0.71 Cr.
Prithvi Exchange (India) Q1 FY27 Results: Net Profit ₹0.7 Cr, Down 36.4% YoY
Prithvi Exchange (India) Ltd reported revenue from operations of ₹1,108 Cr (+29.4% YoY) and net profit of ₹0.7 Cr (-36.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.7 Cr · -36.4% YoY
Other regulatory approval announcements
All →Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.
Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.